FDA Inspection
BSP Pharmaceuticals SpABSP Pharmaceuticals SpA – FDA Inspection, Dec 16, 2016
Record Details
This FDA Inspection record concerns BSP Pharmaceuticals SpA, with an inspection on December 16, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · dbd27341-8470-41b0-8ef0-5e3534fc848e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1016102
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of BSP Pharmaceuticals SpA
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 29, 2024 | Not classified | Office of Inspections and Investigations | |
| November 12, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 21, 2018 | Not classified | Office of Inspections and Investigations | |
| October 20, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 26, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BSP Pharmaceuticals SpA
- FDA Inspection 1232171 - 2024-02-29
- FDA Inspection 1172555 - 2021-11-12
- FDA Inspection 1071722 - 2018-09-21
- FDA Inspection 1091112 - 2017-10-20
- FDA Inspection 935609 - 2015-06-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.